Monitoring the appropriate prescription of low molecular weight heparins and Fondaparinux through administrative data. A retrospective observational study in the Tuscany region.
<h4>Introduction</h4>Low Molecular Weight Heparins (LMWHs) and Fondaparinux have been widely used as anticoagulants. Mass prescription may lead to prescriptive inappropriateness, which causes Heparin-induced thrombocytopenia and other side effects.<h4>Objectives</h4>The study...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2023-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0291628 |
| _version_ | 1827812021206253568 |
|---|---|
| author | Giaele Moretti Bruna Vinci Simona Zito Alessia Caputo Francesco Attanasio Milena Vainieri |
| author_facet | Giaele Moretti Bruna Vinci Simona Zito Alessia Caputo Francesco Attanasio Milena Vainieri |
| author_sort | Giaele Moretti |
| collection | DOAJ |
| description | <h4>Introduction</h4>Low Molecular Weight Heparins (LMWHs) and Fondaparinux have been widely used as anticoagulants. Mass prescription may lead to prescriptive inappropriateness, which causes Heparin-induced thrombocytopenia and other side effects.<h4>Objectives</h4>The study investigates the appropriate prescription of LMWHs and Fondaparinux in Tuscany. We aim to validate the crude measure of prescription appropriateness of the Key Performance Indicator (KPI) "Patients treated with LMWHs and Fondaparinux every hundred residents in Tuscany" as a proxy for monitoring prescription appropriateness.<h4>Methods</h4>To compare a crude KPI based only on drug consumption with a refined KPI based on exclusions listed in the clinical guidelines, a retrospective observational cohort study was carried out, using the RECORD guidelines for the year 2019. The refined indicator is computed via record linkage of different datasets regarding (a) pharmaceutical services; (b) hospital discharge records; (c) outpatient services; and (d) birth certificates. We apply exclusion criteria to identify the cohort of patients. Values of the KPI are compared, by ranking, with those obtained from its refined version. A Spearman test was performed to validate the use of the crude KPI as a proxy.<h4>Results</h4>208,717 LMWH and Fondaparinux users are identified, of which 103,299 fall within the study's inclusion criteria. 16,817 (16%) of LMWHs and Fondaparinux users are classified as high consumption. The refined version of the KPI produces the same ranking results in terms of local health districts (rho = 0.98 p<0.01).<h4>Conclusions</h4>Although the crude KPI is less refined and detailed than the adjusted indicator computed by our study, it has proven capable to provide an accurate snapshot of the use of these drugs across the region. This analysis is useful to enable regional and local managers to run rapid and simple indicators to monitor the appropriateness of LMWHs and Fondaparinux. This analysis should be reviewed periodically to confirm its accuracy. |
| first_indexed | 2024-03-11T23:13:29Z |
| format | Article |
| id | doaj.art-6cf2a74e9c7246eaaddf84f12f52eb3e |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-03-11T23:13:29Z |
| publishDate | 2023-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-6cf2a74e9c7246eaaddf84f12f52eb3e2023-09-21T05:32:29ZengPublic Library of Science (PLoS)PLoS ONE1932-62032023-01-01189e029162810.1371/journal.pone.0291628Monitoring the appropriate prescription of low molecular weight heparins and Fondaparinux through administrative data. A retrospective observational study in the Tuscany region.Giaele MorettiBruna VinciSimona ZitoAlessia CaputoFrancesco AttanasioMilena Vainieri<h4>Introduction</h4>Low Molecular Weight Heparins (LMWHs) and Fondaparinux have been widely used as anticoagulants. Mass prescription may lead to prescriptive inappropriateness, which causes Heparin-induced thrombocytopenia and other side effects.<h4>Objectives</h4>The study investigates the appropriate prescription of LMWHs and Fondaparinux in Tuscany. We aim to validate the crude measure of prescription appropriateness of the Key Performance Indicator (KPI) "Patients treated with LMWHs and Fondaparinux every hundred residents in Tuscany" as a proxy for monitoring prescription appropriateness.<h4>Methods</h4>To compare a crude KPI based only on drug consumption with a refined KPI based on exclusions listed in the clinical guidelines, a retrospective observational cohort study was carried out, using the RECORD guidelines for the year 2019. The refined indicator is computed via record linkage of different datasets regarding (a) pharmaceutical services; (b) hospital discharge records; (c) outpatient services; and (d) birth certificates. We apply exclusion criteria to identify the cohort of patients. Values of the KPI are compared, by ranking, with those obtained from its refined version. A Spearman test was performed to validate the use of the crude KPI as a proxy.<h4>Results</h4>208,717 LMWH and Fondaparinux users are identified, of which 103,299 fall within the study's inclusion criteria. 16,817 (16%) of LMWHs and Fondaparinux users are classified as high consumption. The refined version of the KPI produces the same ranking results in terms of local health districts (rho = 0.98 p<0.01).<h4>Conclusions</h4>Although the crude KPI is less refined and detailed than the adjusted indicator computed by our study, it has proven capable to provide an accurate snapshot of the use of these drugs across the region. This analysis is useful to enable regional and local managers to run rapid and simple indicators to monitor the appropriateness of LMWHs and Fondaparinux. This analysis should be reviewed periodically to confirm its accuracy.https://doi.org/10.1371/journal.pone.0291628 |
| spellingShingle | Giaele Moretti Bruna Vinci Simona Zito Alessia Caputo Francesco Attanasio Milena Vainieri Monitoring the appropriate prescription of low molecular weight heparins and Fondaparinux through administrative data. A retrospective observational study in the Tuscany region. PLoS ONE |
| title | Monitoring the appropriate prescription of low molecular weight heparins and Fondaparinux through administrative data. A retrospective observational study in the Tuscany region. |
| title_full | Monitoring the appropriate prescription of low molecular weight heparins and Fondaparinux through administrative data. A retrospective observational study in the Tuscany region. |
| title_fullStr | Monitoring the appropriate prescription of low molecular weight heparins and Fondaparinux through administrative data. A retrospective observational study in the Tuscany region. |
| title_full_unstemmed | Monitoring the appropriate prescription of low molecular weight heparins and Fondaparinux through administrative data. A retrospective observational study in the Tuscany region. |
| title_short | Monitoring the appropriate prescription of low molecular weight heparins and Fondaparinux through administrative data. A retrospective observational study in the Tuscany region. |
| title_sort | monitoring the appropriate prescription of low molecular weight heparins and fondaparinux through administrative data a retrospective observational study in the tuscany region |
| url | https://doi.org/10.1371/journal.pone.0291628 |
| work_keys_str_mv | AT giaelemoretti monitoringtheappropriateprescriptionoflowmolecularweightheparinsandfondaparinuxthroughadministrativedataaretrospectiveobservationalstudyinthetuscanyregion AT brunavinci monitoringtheappropriateprescriptionoflowmolecularweightheparinsandfondaparinuxthroughadministrativedataaretrospectiveobservationalstudyinthetuscanyregion AT simonazito monitoringtheappropriateprescriptionoflowmolecularweightheparinsandfondaparinuxthroughadministrativedataaretrospectiveobservationalstudyinthetuscanyregion AT alessiacaputo monitoringtheappropriateprescriptionoflowmolecularweightheparinsandfondaparinuxthroughadministrativedataaretrospectiveobservationalstudyinthetuscanyregion AT francescoattanasio monitoringtheappropriateprescriptionoflowmolecularweightheparinsandfondaparinuxthroughadministrativedataaretrospectiveobservationalstudyinthetuscanyregion AT milenavainieri monitoringtheappropriateprescriptionoflowmolecularweightheparinsandfondaparinuxthroughadministrativedataaretrospectiveobservationalstudyinthetuscanyregion |